Literature DB >> 1458669

Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview).

M Zaug1, M Bergstraesser.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1458669     DOI: 10.1111/j.1365-2230.1992.tb00281.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  13 in total

Review 1.  Onychomycosis in the elderly.

Authors:  A K Gupta
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 2.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 3.  Clinical and economic factors in the treatment of onychomycosis.

Authors:  T R Einarson; A K Gupta; N H Shear; S Arikian
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 4.  Pharmacokinetics of antifungal agents in onychomycoses.

Authors:  D Debruyne; A Coquerel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection.

Authors:  A Vélez; M J Linares; J C Fenández-Roldán; M Casal
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 6.  Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology).

Authors:  D W Denning; E G Evans; C C Kibbler; M D Richardson; M M Roberts; T R Rogers; D W Warnock; R E Warren
Journal:  BMJ       Date:  1995-11-11

Review 7.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Onychomycosis. New therapies for an old disease.

Authors:  A K Gupta; R K Scher; P De Doncker; D N Sauder; N H Shear
Journal:  West J Med       Date:  1996-12

Review 9.  Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.

Authors:  M Haria; H M Bryson
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

10.  [Onychomycosis].

Authors:  D Reinel
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.